Pharma Journalist

LEAP HR: Life Sciences West
2025-04-22 - 2025-04-24 | Grand Hyatt San Francisco, 345 Stockton St, San Francisco, CA, 94108, United States
LEAP HR: Life Sciences West is your chance to explore how leading and emerging biopharma organizations are navigating industry volatility and preparing for the workforce of tomorrow. As the sector recovers from funding challenges and workforce reductions, discover innovative ways to align your HR strategy with evolving business needs in 2025 and beyond.
Join 200+ HR leaders to uncover how the most agile organizations are reshaping total rewards strategies to gain a competitive edge in a fiercely competitive talent market. Learn how they’re redefining employee engagement to boost retention and creating flexible workforce planning strategies to adapt to rapid industry changes.
This is your opportunity to rethink HR practices and position your organization for long-term success in Life Sciences.
To know more visit: https://ter.li/fxwk88

4th ADC Analytical Development Summit
2025-04-28 - 2025-04-30 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Unlock the Future of ADC Analytics at the 4th ADC Analytical Development Summit!
When: April 2025
Where: Boston
The 4th ADC Analytical Development Summit is back, bringing together top minds and innovators to tackle the unique analytical challenges of antibody-drug conjugates. With ADCs becoming more complex and regulatory requirements tightening, this event will be your ultimate guide to mastering strategies that ensure high-quality products and seamless regulatory submissions.
View the program here: https://ter.li/hi4hm1

Why You Can’t Miss This Summit:
3 Days of Cutting-Edge Scientific Content
Explore sessions that cover critical topics, including:

Optimizing DAR quantification
Improving aggregation analysis
Refining impurity profiling for advanced ADC development

25+ Expert Speakers
Learn from top industry leaders and innovators, featuring experts from:

AstraZeneca
AbbVie
Sutro Biopharma
Merck
…and many more!

6+ Hours of Interactive Workshops
Participate in hands-on workshops to dive deeper into:

Strategies for accelerated approvals
Advanced profiling techniques for product characterization
Potency optimization for improved therapeutic outcomes
Crafting data packages for smooth regulatory submissions

5+ Hours of High-Impact Networking
Connect with over 120 analytical scientists and quality control specialists to build valuable collaborations and share expertise.
Find out more here: https://ter.li/hi4hm1

2nd Measuring Patient Engagement Summit
2025-04-29 - 2025-05-01 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
As the healthcare industry evolves, patient engagement has become a crucial factor in shaping clinical trials, accelerating regulatory approvals, and improving the overall patient experience.
Yet, amidst a challenging funding environment, empowered patients rightfully demanding greater involvement in treatment decisions, and regulatory bodies requiring transparent reporting of patient engagement activities, it has become more critical than ever to establish quantitative measures for assessing the impact of these initiatives.
The 2nd Annual Measuring Patient Engagement Summit 2025 is the premier event dedicated to addressing this challenge. Bringing together top experts from Patient Engagement, Advocacy, Affairs, Experience, Insights, and Marketing, this summit offers a platform for thought leaders to share data-driven strategies and actionable insights. Attendees will explore innovative case studies that showcase how patient engagement initiatives can be effectively measured, ensuring they deliver real impact while meeting compliance and ROI expectations.
Key topics will include:

Establishing standardized metrics for patient engagement success
Aligning patient engagement strategies with regulatory expectations
Demonstrating ROI to internal and external stakeholders
Leveraging patient insights to improve trial design and healthcare outcomes

By uniting industry leaders to develop a consistent framework for measuring patient engagement, this event ensures that patient-centered innovation remains at the forefront of healthcare transformation.
Join us to drive measurable, meaningful progress in patient engagement — because when we quantify what matters, we create a healthcare system that works for everyone.
To know more visit: www.measuring-patient-engagement-summit.com

2nd GLP-1-Based Therapeutics Summit
2025-04-29 - 2025-05-01 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
The 2nd GLP-1-Based Therapeutics Summit is an exclusive gateway to competitive intelligence into the continued potential of cutting-edge GLP-1s for obesity, weight loss, diabetes, and beyond. Join us to hear the latest clinical data on combination therapies to enhance muscle preservation, indication expansion into new areas, and strategies to improve the efficacy, tolerability, and durability of GLP-1s. With these drugs continuing to dominate the headlines, there is no better time to unite with 100+ C-level executives, decision-makers, and scientists at the forefront of the rapidly evolving world of GLP-1-Based therapeutics.
Learn more: https://ter.li/b0yt9f

3rd mRNA Process Development & Manufacturing Summit Europe
2025-05-06 - 2025-05-08 | Hotel Palace Berlin, Germany
The 3rd mRNA Process Development & Manufacturing Summit 2025 returns as Europe’s premier industry-focused forum, dedicated to optimizing process development for mRNA therapeutics and vaccines. This event will address end-to-end process optimisation, regulatory compliance to streamline approvals, while also advancing scalable and cost-efficient manufacturing solutions, to support drug developers in delivering safer and more effective mRNA drugs to patients faster.
Bringing together leading experts from CEPI, Merck, CureVac, BioNTech, Altamira, Genevation, and more, this summit will showcase cutting-edge advancements in end-to-end process development and manufacturing to support the production of high-quality, cost-effective mRNA therapeutics at scale.
Download the event guide for full details: https://ter.li/4omn9n

2nd ADC Payload Summit
2025-05-06 - 2025-05-08 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The 2nd ADC Payload Summit (May 6-8 | Boston, MA) is the first and only conference exclusively focusing on ADC payloads, helping you to reimagine the medicinal chemistry of traditional cytotoxic payloads while scouting the next generation of ADC payload innovations.

With novel payload categories such as degraders, RNA polymerase II inhibitors, immunomodulators, gene silences, and splice modulators entering the clinic, don’t miss this opportunity to meet with fellow peers to explore the benefits of these diverse mechanisms of action to develop the next blockbuster ADC.
This event will also feature cutting-edge data presentations from emerging players in the field, including Lycia Therapeutics and Heidelberg Pharma, showcasing their latest advancements in payload technologies and clinical trial outcomes. With 80+ professionals from across the ADC landscape in attendance, the summit offers ample networking opportunities to foster collaboration, exchange ideas, and drive the future of ADC therapy forward.
Over three days of deep discussions and collaborative sessions, attendees will gain practical insights into optimizing payload efficacy, improving structure-activity relationships, and exploring the latest payload classes entering the clinic.
Here are some of the agenda highlights you cannot afford to miss:
– Gain insights from Eisai on “Engineering STING/TLR Agonist Payloads to Amplify Anti-Tumor Immune Responses Without Triggering Cytokine Induction” exploring the therapeutic niche and potential of STING agonist payloads.
– Join Takeda in “Navigating the Evolution of ADC Payloads – From Topo1 Success to Future Innovation” to discuss why Topo1 inhibitors dominated the clinic so fast, what other modes of action and payload classes need to do to match that clinical success, and where there is whitespace for novel payloads to gain ground in a competitive ADC landscape.
– Hear from Merck on “Accelerating Degrader-Antibody Conjugate Design Through Strategic Integration of Traditional ADC & Expertise in TPD” to learn about translating physicochemical property optimization strategies from traditional ADCs to address unique degrader payload solubility and stability challenges.
Don’t miss this opportunity to connect with the ADC community and shape the future of payload design. Join us in Boston for this exclusive event and be at the forefront of ADC innovation.
To know more visit: https://ter.li/j0dvm6

4th ALS Drug Development Summit
2025-05-12 - 2025-05-14 | Revere, 200 Stuart St, Boston, MA, 02116, United States
The ALS Drug Development Summit is the definitive industry-led forum dedicated to advancing breakthroughs in ALS therapeutics. With the field evolving rapidly, recent milestones—such as Insitro’s AI-driven target discovery with Bristol Myers Squibb and Dewpoint Therapeutics’ collaboration with Mitsubishi Tanabe Pharma America on TDP-43 condensate modulators—highlight the momentum in novel drug discovery. Meanwhile, QurAlis’ clinical trials for QRL-101 and QRL-201 and innovations in biomarker platforms are reshaping the treatment landscape.
Join 200+ scientific leaders in Boston to tackle key challenges in target validation, biomarker development, and clinical trial optimization—driving progress toward effective ALS and FTD therapies.
To know more visit: https://ter.li/48rlwg

3rd Precision Medicine in Inflammatory Bowel Disease Summit
2025-05-13 - 2025-05-15 | Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States
Following a year of exceptional progress in IBD drug development, fierce competition in clinical trials for Chron’s Disease and Ulcerative Colitis remains high, and it’s time for biopharma to push the boundaries of efficacy and distinguish their therapies amongst the market.
Featuring three days of data-driven sessions from 25+ world-class speakers, the 3rd Precision Medicine in Inflammatory Bowel Disease returns as the field’s most comprehensive learning and networking forum; dedicated to showcasing the latest data and advances in IBD therapeutic development.
See the full program here: https://ter.li/tjjok6
With transformative advancements in disease understanding, AI-powered biomarker development, patient stratification, and advanced monitoring techniques paving the way for a new era of precision IBD therapies, join 80+ IBD specialists to:

Refine models and proof-of-concept studies to reduce clinical trial failure rates and improve translational outcomes
Innovate treatment pathways to optimize safety and efficacy
Minimize adverse events while enhancing therapeutic synergies
Leverage emerging therapeutic modalities to refine patient selection and optimize therapeutic outcomes

When & Where: May 13-15, 2025 | Boston, MA
Who: 80+ Precision Medicine, Diagnostics, Translational, Clinical, Computational Biology, Gastrointestinal and Inflammation experts
Agenda: https://ter.li/tjjok6

TPD & Induced Proximity Pharma Partnering Summit
2025-05-19 - 2025-05-20 | The Colonnade Hotel, 120 Huntington Ave, Boston, MA, 02116, United States
From molecular glue discovery to the development of degrader-antibody conjugates, pharma is transforming through strategic transactions and by leveraging protein degradation technologies to expand target discovery and drug previously ‘undruggable’ targets.
This provides biotech with the opportunity to understand pharma’s targets of interest and the options for increased specificity and selectivity compared to traditional molecules.
Join the TPD & Induced Proximity Pharma Partnering Summit to accelerate partnership interest in your protein degradation pipeline or platform, by hearing first-hand:

What: What are pharma’s targets of interest, and what data is sparking or prohibiting deal-making across TPD?
Who: Who is the right person at each pharma, specifically for induced proximity assets?
How: How are pharma analyzing data for a research collaboration versus a licensing deal?

VIEW THE FULL EVENT GUIDE
Secure your place here or get in touch with the team – info@hansonwade.com

4th GPCRs-Targeted Drug Discovery Summit
2025-05-20 - 2025-05-22 | Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States
The 4th GPCR-Targeted Drug Discovery Summit: Transforming the Discovery of Novel GPCR-Targeted Therapies.
With positive clinical read outs by Tectonic Therapeutics and recent funding rounds for Confo Therapeutics & Septerna, the potential for novel GPCR drug classes to treat a plethora of diseases grows. Now more than ever, there is a need for the community to come together to share scientific advancements and collaboration opportunities across the full spectrum of GPCR drugs, from small molecules to therapeutic proteins and antibodies.
The 4th GPCRs-Targeted Drug Discovery Summit is returning to Boston to showcase the hottest targets of interest, mechanism of action of new GPCR ligands, cutting-edge computational tools to identify high-potential candidates, and effective translational strategies to drive forward discovery & development pipelines to patients in need.

Find out everything you need to know about the Summit here: https://ter.li/2c54a7

6th Gene Therapy Analytical Development Summit Europe
2025-05-20 - 2025-05-22 | Novotel London West, 1 Shortlands, Hammersmith, London, W6 8DR, United Kingdom
The 6th Gene Therapy Analytical Development Summit Europe is the leading platform for advancing gene therapy analytics, from IND/IMPD filings to clinical trials and regulatory approvals. As the field moves toward late-stage development, gain industry-focused insights tailored for Europe.
Join 24+ experts to tackle characterisation, stability, contamination risks, and comparability across vectors and diseases. Network with biotech, pharma, MHRA, and British Pharmacopoeia to share solutions and shape the future of gene therapy.
Don’t miss the chance to explore analytical precision, QC strategy, and the delivery of safe, effective therapies!
To know more visit: https://ter.li/w8deua

3rd Retinal Imaging Biomarkers & Endpoints Summit
2025-05-27 - 2025-05-29 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
The 3rd Retinal Imaging Biomarkers & Endpoints Summit will bring together leading experts spanning medical directors, researchers, clinical, and imaging scientists from more than 30 organizations spearheading ophthalmic development with deep learning systems and sophisticated AI imaging technologies. It’s here they will explore the latest advancements in retinal imaging, biomarkers, and endpoints for ophthalmic drug development.
This highly anticipated meeting will delve into the evolving landscape of retinal diseases, offering in-depth discussions on innovative imaging techniques, biomarker discovery, and the critical role of endpoints in clinical trials. Attendees will have the opportunity to engage with top-tier scientists, researchers, and industry leaders who will be presenting cutting-edge research, techniques, and case studies, providing you with hyper-relevant insights to accelerate your ophthalmic development.
Topics will cover a range of retinal conditions, including dry and wet AMD, GA, GR, and DME, focusing on the identification and validation of biomarkers that are vital for diagnosis, prognosis, and treatment response assessment. This meeting is the perfect bridge for those developing and using novel technologies to ensure the efficacious development of endpoints for regulatory approval.
Attendees will benefit from interactive workshops, panel discussions, and case studies, providing practical insights into the real-world challenges and opportunities in retinal disease research. Plus, with 8+ hours of dedicated networking sessions designed to ensure attendees get to meet everyone in the room, it’s a fantastic opportunity to build valuable connections and strengthen collaboration which will aid in fostering partnerships that will drive the future of retinal imaging and treatment outcomes.
And with sessions being delivered by Alexion, Opus Genetics, Inflammx, Bausch + Lomb, REGENXBIO, and many more you won’t want to miss this!
Whether you’re a researcher, drug developer, clinician or solution provider, the 3rd Retinal Imaging Biomarkers & Endpoints Summit promises to be a pivotal point in the calendar for those involved in the development of therapies for retinal diseases.
Join us to be at the forefront of this rapidly advancing field and contribute to the next wave of innovations in retinal health…
View the event guide for more information: https://ter.li/hcmzr0
Secure your pass: https://ter.li/tq8jmz

2nd Cell & Gene Therapy Pricing & Reimbursement Summit
2025-05-27 - 2025-05-29 | Marriott Washington Capitol Hill, 175 L Street NE, WA, 20002, United States
Current limitations across pricing, coverage, and payment frameworks are lasering out and hindering global access to many approved cell and gene therapies (CGTs). The Cell & Gene Therapy Pricing & Reimbursement Summit is here to change that.
Returning for its 2nd edition, this unique summit will share real-world case studies of success and setback in ensuring patients can access CGTs to spearhead reform in this thorny landscape.
Industry-led discussions will center on innovative payment models being developed and applied, new stop-loss and reinsurance programs, and how leading companies are ensuring coverage and uptake of their commercialized therapies. You’ll also leave with actionable learnings from recent CMS policy changes, including the Access Model, Medicaid Drug Rebate Program Final Rule, and proposed increases to inpatient CAR-T reimbursement rates.
Join leading biopharma, government agencies, commercial payers, academics, and market access-specialist service providers – to align on the current market access strategy and policy challenges hindering widespread adoption of these ground-breaking therapies, enhance your payer coverage and improve patient access.
To know more visit: https://ter.li/0g5eq9

4th Circular & Self-Amplifying RNA Therapeutics Summit
2025-05-28 - 2025-05-29 | The Colonnade Hotel, 120 Huntington Ave, Boston, MA, 02116, United States
Join the 4th Circular & Self-Amplifying RNA Therapeutics Summit!
Unleashing the Next Generation of RNAs for Widespread Therapeutic Applications
With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-amplifying RNAs to provide improved stability, durability, longevity and efficacy for treating a wide array of diseases.
This May, the 4th Circular & Self-Amplifying RNA Therapeutics Summit (previously known as ‘Next Generation RNA Therapeutics Summit) is landing back in Boston, as the unique opportunity to unite with leading stakeholders in the next generation RNA field, including the likes of Sail Biomedicines, Merck, Novo Nordisk, Replicate Bioscience and more. This is your one-stop shop to hear the latest approaches and applications of circular and self-amplifying RNA therapeutics and vaccines and gain actionable insights for fast-tracking your RNA programs toward the clinic.
Join 80+ RNA experts navigating through challenges such as RNA design, delivery, purity, and manufacturing to accelerate high-quality and scalable next-generation RNA therapeutics and vaccines towards approval and the patients in need.
To know more visit: https://ter.li/lemzh2

3rd Gene Therapy Potency Assay Summit
2025-05-28 - 2025-05-29 | Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States
Accelerating the Route to Commercialization with Robust Potency Assay Development
Following a challenging year in the gene therapy field, the 3rd Gene Therapy Potency Assay Summit returns at a crucial time when drug developers increasingly recognize that a robust potency assay is fundamental to both clinical success and commercial viability. As regulatory expectations continue to evolve, it has never been more important to develop assays that are accurate, reproducible, and aligned with regulatory standards.
While many industry meetings touch on potency in a broad or non-technical manner, this summit stands apart as the only event fully dedicated to the complexities of potency assay development. With an emphasis on deep technical discussions, attendees will gain unparalleled insights into phase-appropriate assay development, methodology advancements, reducing lot-to-lot variability, and meeting evolving regulatory expectations. By bringing together a specialized community of Analytical Development, Quality Control, and Regulatory experts, this meeting offers a unique platform to discuss challenges, share strategies, and explore innovative solutions.
One of the key highlights of this year’s agenda is the session “Navigating Regulatory Requirements for Gene Therapy Potency Assays”, presented by Melody Dai, Vice President, Head of Regulatory Affairs & CMC at Novasenta. This session, taking place at 9:00 AM on Day 1, will provide an in-depth exploration of regulatory strategies for potency assays, covering both early and ongoing regulatory engagement. Attendees will learn how to build effective relationships with regulatory agencies, navigate evolving requirements, and prepare for critical regulatory meetings and submissions. By leveraging insights from experts with hands-on experience in clinical-stage gene therapy products, this session will offer practical guidance that extends beyond theoretical discussions.
With a carefully curated agenda and contributions from industry leaders, the 3rd Gene Therapy Potency Assay Summit provides an essential opportunity to advance potency assay strategies, enhance regulatory preparedness, and accelerate the path to commercialization. Whether you are refining your assay methodologies, tackling regulatory complexities, or preparing for the next phase of development, this event will equip you with the expertise and connections needed to drive success in gene therapy.
Find Out More Now!

2nd Structure-Based Drug Design Summit
2025-06-03 - 2025-06-05 | Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States
With tightening budgets and increasing pressure to de-risk R&D, pharma and biotech are shifting their focus toward smarter, more efficient drug design. Companies are investing more in enabling technologies—from computational modeling and AI-driven predictions to structural biology techniques like Cryo-EM, NMR, and X-ray crystallography—to improve rational drug design and enhance decision-making early in discovery.
While AI-powered structure prediction is transforming the landscape—recognized by the 2024 Nobel Prize for Google DeepMind’s AlphaFold2— its true impact depends on experimental validation. The ability to integrate computational insights with high-resolution structural data is now essential for unlocking complex targets and accelerating drug discovery.
Cryo-EM continues to push the limits of resolution for complex targets and Cryo-ET is emerging as a potential game-changer for biopharma – the future of structure-based drug design is here.
The 2nd Structure-Based Drug Design Summit is the only industry-dedicated meeting bringing together the latest advancements in integrative structural biology and computational tools to accelerate early drug discovery. Across three days of expert-led discussions and case studies, you’ll gain insights into how leading scientists are leveraging Cryo-EM, NMR, X-ray crystallography, and AI to solve high-value targets and drive rational drug design across small molecules, peptides, biologics, and vaccines.
With coverage of design of TPDs, molecular glues, vaccines, antibodies, and mRNA, GPCRs and membrane protein targeting therapeutics plus much more!
The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, protein engineers, and computational chemists in Boston this June and be part of the next wave of structure-based drug design innovation.

Innovation in Psychosis Therapeutics Summit
2025-06-09 - 2025-06-11 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The Innovation in Psychosis Therapeutics Summit is the premier industry forum dedicated to advancing next-generation approaches for psychosis treatment. As 2025 marks a pivotal year for psychosis drug development—with a surge in clinical advancements and key collaborations gaining momentum—this inaugural event unites the brightest minds in biotech and pharma to overcome critical challenges in drug discovery and development.

Designed specifically for R&D leaders, this summit is uniquely positioned to tackle the biggest hurdles in the field, including translational validity, patient heterogeneity, placebo effect, and trial scalability. By bringing together 60+ key stakeholders from discovery, preclinical, translational, and clinical development, this meeting provides a platform to collaborate, exchange insights, and shape the future of psychosis treatment.
With the growing urgency to address the significant unmet need in psychosis and the limitations of current atypical antipsychotics, the time is now to drive innovation forward. Join the conversation as industry pioneers build on Cobenfy’s breakthrough success and explore cutting-edge strategies to develop more effective, better-tolerated therapeutics across the psychosis spectrum.
Don’t miss this brand-new opportunity to connect with thought leaders, gain critical insights, and be at the forefront of transforming psychosis R&D.
To know more visit: https://ter.li/9yj2vx

7th Annual Allogeneic Cell Therapies Summit
2025-06-10 - 2025-06-12 | Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States
With the autoimmune wave breathing financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, the allogeneic community are eagerly anticipating what lies ahead!
Making now the ideal time to attend the 7th Annual Allogeneic Cell Therapies Summit (June 10-12 | Boston, MA), your flagship forum uniting the top allogeneic developers including Atara Bio, Adicet Bio, Senti Bio, Glycostem and more.
What Will 2025 Offer?

Ground-breaking Clinical Readouts: Dive into the latest results from CAR-T therapies with Atara Bio and Adicet Bio.
Solid Tumor Breakthroughs: Hear from Senti Bio, NKILT Therapeutics, and Synaptimmune on how allogeneic therapies are targeting the tumor microenvironment to unlock entirely new indications.
Manufacturing at Scale: Learn how Tevogen and Cell BioEngines are navigating the complexities of scalable, high-quality manufacturing to make these therapies commercially viable.
Beyond Oncology: Broaden your scope by discovering how Biosyngen and Adicet Bio are leveraging allogeneic platforms to address autoimmune disorders.

As regulatory frameworks evolve to accommodate these revolutionary therapies and investment creeps back into allogeneic development, staying informed is no longer optional. Get involved today to be part of the conversations solving today’s challenges and shaping tomorrow’s breakthroughs.
Find out more: https://ter.li/o21go2

2nd Annual IMPACCT Real World Evidence Summit Europe
2025-06-10 - 2025-06-12 | Steigenberger Airport Hotel, Amsterdam, Stationsplein Zuid-West 951, Schiphol, 1117 CE, Netherlands
This year’s IMPACCT Real World Evidence Europe conference is the only case-study led industry forum providing actionable insights into numerous challenges such as optimizing evidence generation plans in early stages, enhancing collaboration between industry and public research to advance RWE, consolidating cross-functional collaboration to improve effectiveness of RWE studies, and exploring actionable study designs that empower patients to elevate RWE utility…
As regulators and payers increasingly elevate the importance of RWE in submission requirements and with an explosion of datasets opening up in parallel with advancing AI, deep learning, and large language models transforming big data analysis, it has never been more critical to keep up with the matrix of country-specific regulatory nuances and industry case studies in optimizing integrated evidence plans, bullet-proofing data quality, and navigating vendor selection.
The 2nd IMPACCT Real World Evidence Summit Europe is the only industry meeting dedicated to uniting experts in RWE and Evidence Generation to consolidate, innovate and apply RWE across the drug development lifecycle, from external control arms to reimbursement.
With a tight focus on leveraging AI for both efficiency gains and big data analysis, the latest on DARWIN and using RWE to support regulatory decision-making, and creating a robust integrated evidence strategy, join 60+ industry pioneers from AstraZeneca, Pfizer, Novartis, Sanofi and more to collaboratively establish best practice and bridge the evidence gap between clinical research and practice, ensuring resilience and success in a dynamic landscape as a successful business partner.
Join us, our speakers, attendees and sponsors to explore strategies, learn efficient data deployment and automation, learn best practices for sharing real-time data and insights cross-functionally, inform your development processes, address biases and study product life cycle management to bridge the gap from clinical trials to real-world evidence.
With over 50 industry pioneers we have the force to form a comprehensive evidence plan, break free from silos, and bridge the gap between clinical research and practice. Get in the room with Presidents, VPs, Directors, Head, Managers and Lead Scientists all on the same mission as you.
This is your one opportunity to liaise with like-minded, driven and curious individuals about industry innovation.
To know more visit: https://ter.li/e8cs7v

Vendor Management & Outsourcing for Clinical Trials Summit
2025-06-10 - 2025-06-12 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Vendor management processes are crucial for ensuring compliance, quality, and timely delivery at every stage, serving as the backbone of successful clinical trials. Acknowledging the transformative impact, the industry is prioritizing the optimization of these intricate processes, making significant investments to enhance key functions, improve performance, and maintain a competitive edge. Despite this professionals managing ancillary lab vendors and CROs lack a dedicated forum to address their unique challenges, until now…
Introducing the Vendor Management & Outsourcing for Clinical Trials Summit, built with the industry to the needs of vendor management, outsourcing and clinical operations professionals.
To know more visit: https://ter.li/d1jemt

4th World ADC Asia Summit
2025-06-10 - 2025-06-12 | Grand Hyatt Incheon, 208 Yeongjonghaeannam-ro 321beon-gil, Jung-gu, Incheon, South Korea
Linking the East to the West in the ADC World | 在ADC世界连接东西方 | ADC 세계에서 동서 연결하기ADCの世界で東西をつなぐ
In 2025, Asia will continue leading ADC innovation, with growth in dual-payload ADCs, bispecific ADCs, and novel linker-payload technologies. Staying informed through clinical updates, connecting with new companies, and building collaborations will be key to seizing emerging opportunities.
The 4th World ADC Asia Summit (June 10-12, 2025, | Incheon, South Korea), part of the globally recognized World ADC series, serves as the premier platform for showcasing the latest advancements in R&D, clinical validation, and commercialization.
This industry-leading event unites Asia’s top innovators with global expertise to drive ADC success across the region.
What’s New in 2025?
Three dynamic tracks covering discovery, preclinical, clinical, and CMC
Exclusive seminar days on ADC fundamentals & Bispecific ADCs – Whether you’re just starting out or a seasoned expert, the program offers something for professionals at every level
Unparalleled networking with leading experts and organizations
A Global Speaker Lineup
With 20+ new companies joining our esteemed panel from China, Japan, Korea, Taiwan, Singapore, the US, and Europe—featuring industry leaders such as AstraZeneca, AbbVie, HoneyBear Biosciences, Chiome Bioscience, and more—this is a must-attend event for anyone in the ADC field.
Learn more here: https://ter.li/iimxna

10th Annual Microbiome Movement Summit
2025-06-23 - 2025-06-25 | Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States
Returning for its 10th anniversary, the Microbiome Movement Summit remains the premier global gathering for microbiome drug developers, uniting experts across discovery, preclinical, translational, regulatory, and commercial sectors to drive innovation in the microbiome space.
Connect with over 140+ experts from diverse fields within microbiome R&D, including representatives from Pulmobiotics, Seres Therapeutics, BiomeBank, and PharmaBiome. Engage in dynamic discussions, forge valuable partnerships, and gain actionable insights that will drive your microbiome research and development forward. This summit is your chance to be at the forefront of microbiome innovation and to collaborate with the brightest minds in the industry.
What’s New for 2025?
– Hear Brand New Insights from Industry Trailblazers: Gain key updates from leaders at Ferring Pharmaceuticals, Siolta Therapeutics, MaaT Pharma, and Corundum Systems Biology as they discuss clinical advancements and commercial strategies shaping the future of microbiome therapeutics.
– 18 New Organizations Taking the Stage: Discover the latest contributions from emerging companies such as Azitra, Kanvas Bio, Alveolus Bio, Microviable Therapeutics, Unilever, Mikrobiomik, Jona, Nestle Health Science, and more, with each presenting their innovative approaches and breakthroughs in microbiome research.
– Unlock the Next Wave of Microbiome-Based Drug Development: Explore groundbreaking synthetic biology innovations, AI-driven strain engineering, and advanced bioinformatics tools that are accelerating the discovery and optimization of microbiome-based therapies.
– Advance Clinical Translation & Regulatory Success: Learn how companies are overcoming challenges in CMC, large-scale manufacturing, and regulatory approval, with insights on recent FDA approvals, IND-enabling studies, and global market access strategies.
Get your copy of the latest brochure here: https://ter.li/cdfr4c

CPHI & PMEC China 2025
2025-06-24 - 2025-06-26 | Shanghai New International Expo Centre, Shanghai, China
CPHI & PMEC China is Asia’s premier pharmaceutical event for sourcing, networking, learning and innovation with over 20 years’ experience of bringing together Chinese and global pharma professionals.

CPHI & PMEC China 2025 will cover more than 230,000 square meters of exhibition area, attract over 90,000 global attendees and 3,500 exhibitors, and hold more than 100 conferences during the exhibition.
CPHI & PMEC China 2025 showcases a wide range of pharmaceutical products and services, including: active pharmaceutical ingredients, Intermediates & fine chemicals, excipients, finished dosage formulation, biopharmaceuticals, natural extracts, CMO & CRO, machinery & equipment, packaging & drug delivery, laboratory equipment, cleanroom & pollution control etc.
Click here to register now.

5th Medical Device Software Development Summit
2025-06-24 - 2025-06-26 | The Royal Sonesta Boston, 40 Edwin H Land Blvd, Cambridge, MA, 02142, United States
The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies, real-world case studies, and expert insights to confidently develop, secure, and regulate cutting-edge medical device software – without compromise.
Dedicated to navigating the complexities of US and global regulations, addressing cybersecurity vulnerabilities, and managing legacy device updates, this summit unites 120+ industry leaders – from medical device giants to innovative start-ups – to explore actionable strategies, share best practices, and collaborate on solutions for ensuring the continuous compliance and security of cutting-edge software in a rapidly evolving market.
What Will you Gain:

Stay Ahead of Regulatory Changes: Gain insights from Biogen, Werfen, and Olympus on the latest FDA, EU MDR, and global compliance updates, ensuring your products meet evolving standards.
Secure & Accelerate Your Software: Learn how Medtronic, RETINA-AI, and Abbott are addressing cybersecurity risks, enhancing software validation, and leveraging AI-powered innovation to streamline development processes.
Unlock AI for Safer, Faster Development: Discover how HeartSciences, Kheiron, and Globe Biomedical are utilizing AI to expedite software testing, improve validation, and bolster cybersecurity, leading to safer and more efficient medical device development.

Don’t miss this summit – join us in Boston this June to stay ahead, gain crucial insights, benchmark and fuse knowledge from software, QA, RA and product teams to align innovation in software with evolving processes, cybersecurity, and global regulatory frameworks in new and legacy devices.
View the full Event Guide here: https://ter.li/cziksw

8th International Neoantigen Summit
2025-06-24 - 2025-06-26 | Steigenberger Airport Hotel Amsterdam, Stationsplein Zuid-West 951, 1117 CE Schiphol, Netherlands, 1117 CE, Netherlands
2024 saw a wealth of clinical progression with Nouscom, CureVac, Transgene and other pioneering companies paving the way for neoantigen based vaccines and therapies to become tolerable, durable medicines to effectively treat cancer.
Ready to unite the global neoantigen community, the 8th International Neoantigen Summit 2025 returns to address key challenges in the discovery, translation and clinical development of safe and cost-effective neoantigen therapies and vaccines to attract investors and ultimately improve the health of patients.
Join neoantigen leaders from the likes of AstraZeneca, Geneos Therapeutics, Evaxion Biotech and many more at this end-to-end meeting, focusing on the development of durable, neoantigen cancer vaccines and cell therapies. With the potential to deliver safe, efficacious personalized or off-the-shelf therapeutic options to patients, this is your chance to collaborate and accelerate the translation of neoantigen-based therapies from discovery to clinical success.
To know more visit: https://ter.li/zdfjes

5th Annual Induced Proximity-Based Drug Discovery Summit
2025-06-25 - 2025-06-26 | The Westin San Diego Bayview, 400 W Broadway, San Diego, CA, 92101, United States
Coming to San Diego, CA for the first time, the 5th Induced Proximity-Based Drug Discovery Summit returns as your intimate learning and networking setting to cover the depth and breadth of proximity-based drugs from stabilization, phosphorylation and methylation to novel lysosome-based degradation to finally drug the undruggable.
Enabling leaders in biopharma and academia to identify novel MoAs, leverage advanced technologies to find targets more efficiently, and optimize chemical structures for more effective therapeutic agents for a wide range of disease areas. Alongside key strategic updates on DUBTACs, RIPTACs, tPRIMEs, RiboTACs and more, it provides granular technical and scientific insights to overcome challenges in accessing diverse chemical matter and designing selective, potent small molecules of tomorrow.
Join 70+ experts in drug discovery, medicinal chemistry, chemical biology and structural biology from leading companies such as Genentech, Halda Therapeutics and Stablix and gain access to genuinely innovative research from breakthrough companies and academic labs pioneering the next generation of induced proximity-based drugs beyond the ubiquitin proteasome system
Download the event guide for full details: https://ter.li/blor1c

4th Liquid Biopsy for Precision Oncology East Coast
2025-06-26 - 2025-06-27 | The Colonnade Hotel, 120 Huntington Ave, Boston, MA, 02116, United States
The 4th Liquid Biopsy for Precision Oncology East Coast Summit returns to Boston with a refreshed agenda, sharpened focus, and a renewed mission: to accelerate access to more sensitive, less invasive testing by addressing the most pressing challenges across the entire patient care continuum.
This year, we’ve updated the Summit’s name and expanded its scope. What began with a focus on early detection and recurrence monitoring has grown to reflect the full breadth of innovation across the liquid biopsy space – from MRD and treatment response to emerging applications in rare diseases, novel analytes, and beyond.
Bringing together leaders in Biomarker Development, Translational Research, Diagnostics, Clinical Development, Pathology, and beyond, this is the go-to East Coast forum for diving deep into the barriers slowing the adoption of liquid biopsy technologies.
Take home actionable insights to ensure you’re maximizing the value of liquid biopsies in your therapeutic development strategies. Shape the future of precision oncology and be part of the conversations that will drive meaningful change for patients worldwide.
What’s more, this event is completely *FREE for drug developers and researchers for the entire 2 day conference, so claim your pass here (it only takes 2 minutes): https://ter.li/mr0yvh
If you need to explore the full event guide in more detail, feel free to download the brochure here: https://ter.li/mxugsc
T&Cs are available on the website.

ESG in Life Sciences Summit West
2025-07-08 - 2025-07-10 | The Clift Royal Sonesta San Francisco, 495 Geary St, San Francisco, CA, 94102, United States
The ESG in Life Sciences Summit West – Mastering ESG Compliance & Strategic Sustainability in Life Sciences in 2025.
As ESG becomes a key differentiator for securing business and investment, life sciences companies are ramping up sustainability efforts – expanding teams, funding new initiatives, and integrating ESG into corporate strategy. Yet, with shifting global reporting requirements, the new administration’s stance on sustainability, and the impact of CSRD on U.S. operations, many companies are struggling to find the golden ticket on how they can future-proof ESG initiatives and ensure accuracy in reporting?
At the same time, mounting pressure from investors, consumers, and employees to accelerate environmental and social initiatives is leaving many searching for the most effective strategies to navigate the evolving ESG landscape.
Following the success of our Boston and European editions, the ESG in Life Sciences Summit West is bringing together senior leaders in ESG, Sustainability, Compliance, Procurement, Supply Chain, and Finance from across the West Coast to:

Decode the impact of evolving U.S. and EU regulations on ESG reporting
Drive sustainable supply chain transformation
Optimize ESG strategies for business growth

Join us in driving the future of Life Sciences sustainability – turning ambition into action, compliance into opportunity, and responsibility into lasting impact for people and the planet! Find out more here: https://ter.li/oggmq8

3rd ADC Toxicity Summit
2025-07-08 - 2025-07-10 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
“Toxicity is the killer of ADCs” and remains the primary challenge limiting ADC success in the clinic. From unpredictable off-target effects to non-translating toxicity profiles and dose limiting toxicities, the industry must address key hurdles in preclinical models, patient selection, ADC design, and cross-disciplinary communication to accelerate the next wave of safer, more effective ADCs.
The 3rd ADC Toxicity Summit is the only industry-led event bringing together toxicology, pharmacology, translational science, and clinical development experts to accelerate bench-to-bedside-to-bench innovation by preventing, predicting, and mitigating toxicities to enhance ADC safety and clinical translation.
To know more visit: https://ter.li/57358v

3rd Obesity & Weight Loss Summit
2025-07-14 - 2025-07-16 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The 3rd Obesity & Weight Loss Summit has been announced and is set to ignite the field. The summit will unite experts to harness novel targets and GLP combination therapies to improve efficacy, tolerability, and longer lasting clinical outcomes.

Join us at this unique, industry-led summit to:

Discover groundbreaking combination therapies and novel targets to minimize and manage side effects to improve patient tolerability with Boehringer Ingelheim and Altimmune
Explore innovative approaches for preserving muscle mass whilst still achieving significant weight loss to prevent sarcopenia with Regeneron and iBio
Investigate cutting-edge advancements in drug delivery technologies, including long-acting formulations and novel administration routes for simpler patient use with Biolexis and Syntis Bio
Learn strategies to drive long-term weight management success by personalizing treatment for more prolonged patient continuation and satisfaction with Prive Bio and Fractyl Therapeutic

Hear from the titans of the pharmaceutical industry – Eli Lilly, Novo Nordisk, AstraZeneca, Altimmune, High Tide Therapeutics, RenBio, and many more – as they share their groundbreaking research and strategies for developing more effective, tolerable, and long-lasting weight management solutions.
Obesity rates are increasing, and the pressure is on for real change. Don’t miss this pivotal opportunity to network with 70+ obesity scientists and drug development experts forge collaborations, and be part of the solution. The future of weight loss treatment is being written now – be there!
For more information, view the full Event Guide here: https://ter.li/rish42
